| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |